in many ways, it's just beginning
doi: 10.1016/S2214-109X(24)00239-0 9
Another clinical trial led by Regeneron is currently evaluating the synergistic effects of trevogrumab and garetosmab in combination with semaglutide in obese patients, with the goal of reducing fat mass while preserving lean mass (NCT06299098)
Prefilled syringes are increasingly adopted for the delivery of monoclonal antibodies, granulocyte colony stimulating factors, and targeted oncology supportive care agents where dose precision and sterility assurance are non-negotiable clinical requirements
Manufactured in a GMP facility
These effects may be helpful for muscles, tendons, ligaments, joints, and digestive tissue, especially for individuals working toward an active lifestyle, weight loss goals, or improved recovery after physical stress